Bioincompatibility: An Overview

Ringoir S. , Vanholder R. An introduction to biocompatibility. Artif Organs 1986; 10: 20–7.

Joist J.H. , Pennington D.G. Platelet reactions with artificial surfaces. Trans Am Soc Artif Intern Organs 1987; 33: 341–4.

Klinkmann H. , Wolf H. , Schmitt E. Definition of biocompatibility. Contrib Nephrol 1984; 37: 70–7.

Marshall J.W. , Ahearn D.J. , Nothum R.J. , Esterly G. , Nolph K.D. , Maher J.F. Adherence of blood components to dialyzer membranes, morphological studies. Nephron 1974; 12: 157–70.

Canavese C. , Stratta P. , Pacitti A. Impaired fibrinolysis in uremia: partial and variable connection by four different dialysis regimes. Clin Nephrol 1982; 82–9.

Speiser W. , Wojta J. , Korninger C. , Kirchheimer J.C. , Zazgornik J. , Binder B.R. Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis. Kidney Int 1987; 32: 280–3.

Vanholder R. , Hoenich N. , Ringoir S. Morbidity and mortality of central venous catheter hemodialysis: a review of 10 years' experience. Nephron 1987; 47: 274–9.

Vanholder R. , Lameire N. , Verbanck J. , van Rattinghe R. , Kunnen M. , Ringoir S. Complications of subclavian catheter hemodialysis: a 5 year prospective study in 257 consecutive patients. Int J Artif Organs 1982; 5: 297–303.

Van Herweghem J.L. , Dhaene M. , Goldman M. Infections associated with subclavian dialysis catheters: the key role of nurse training. Nephron 1986; 42: 116–9.

Griffith B.P. , Hardesty R.L. , Kormos R.L. Temporary use of the Jarvik-7 total artificial heart before transplantion. New Engl J Med 1987; 316: 130–4.

Levinson M.M. , Smith R.G. , Cork R.C. Thromboembolic complications of the Jarvik-7 total artificial heart: case report. Artif Organs 1986; 10: 236–44.

Eberhart R.C. Progress in thromboresistant materials research. Am Soc Artif Intern Organs J 1983; 6: 45–6.

Lazarus J.M. Complications of hemodialysis. Kidney Int 1980; 18: 783–96.

Dubrow A. , Flamenbaum W. , Mittman N. , Hall J. , Zinn J. Safety and efficacy of epoprostenol (PGI₂) versus heparin (H) in hemodialysis (HD). Trans Am Soc Artif Intern Organs 1984; 30: 52–4.

Schrader J. , Stibbe W. , Armstrong V.W. Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemodiafiltration. Kidney Int 1988; 33: 890–6.

Sung Wan Kim , Ebert C.D. , Lin J.Y. , McRea J.C. Nonthrom-bogenic polymers. Pharmaceutical approaches. Am Soc Artif Intern Organs J 1983; 6: 76–87.

Nosé Y. Totally implantable artificial organ: cardiac prosthesis. Artif Organs 1986; 10: 103–13.

Kaplow L.S. , Goffinet J.A. Profound neutropenia during the early phase of hemodialysis. JAMA 1968; 203: 1135–7.

Craddock P.R. , Fehr J. , Dalmasso A.P. , Brigham K.L. , Jacob H.S. Hemodialysis leukopenia. Pulmonary vascular leu-kostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977; 59: 879–88.

Jacob H.S. , Craddock P.R. , Hammerschmidt D.E. , Moldow C.F. Complement-induced granulocyte aggregation. An unsuspected mechanism of disease. N Engl J Med 1980; 302: 789–94.

Hakim R.M. Clinical sequelae of complement activation in hemodialysis. Clin Nephrol 1986; 26: S9–S12.

Klinkmann H. , Falkenhagen D. , Courtney J.M. Biomaterials and biocompatibility in hemodialysis. Contr Nephrol 1987; 55: 231–49.

Chenoweth D.E. , Cheung A.K. , Ward D.M. , Henderson L.W. Anaphylatoxin formation during hemodialysis: comparison of new and reused dialyzers. Kidney Int 1983; 24: 770–4.

Chenoweth D.E. Biocompatibility of hemodialysis membranes. Evaluation with C3a anaphylatoxin radioimmunoassays. Am Soc Artif Intern Organs J 1984; 7: 44–9.

Hakim R.M. , Fearon D.T. , Lazarus J.M. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 1984; 26: 194–200.

Vanholder R.C. , Pauwels R.A. , Vandenbogaerde J.F. , Lamont H.H. , Van Der Straeten M.E. , Ringoir S.M. Cuprophan reuse and intradialytic changes of lung diffusion capacity and blood gasses. Kidney Int 1987; 32: 117–22.

Lysaght M.J. Hemodialysis membranes in transition. Contr Nephrol 1988; 61: 1–17.

Pusineri C.P. , Paris J.M. Hemodialysis materials. Contr Nephrol 1988; 62: 1–12.

Lewis S.L. , Van Epps D.E. , Chenoweth D.E. Leucocyte C5a receptor modulation during hemodialysis. Kidney Int 1987; 31: 112–20.

Lewis S.L. , Van Epps D.E. Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 1987; 9: 381–95.

Nguyen A.T. , Lethias C. , Zingraff J. , Herbelin A. , Naret C. , Descamps-Latscha B. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 1985; 28: 158–67.

Vanholder R. , Dhondt A. , Van Landschoot N. , Waterloos M.A. , Ringoir S. Phagocytic activity of leucocytes induced by different dialyzer membranes. Contr Nephrol (in press).

Vanholder R.C. , Dhondt A. , Ringoir S.M.G. Challenge of phagocyte metabolism by extracorporeal circulation and membrane contact. Trans Amer Soc Artif Intern Organs.

Betz M. , Haensch G. , Rauterberg E. , Bommer J. , Ritz E. Cuprammonium membranes stimulate interleukin 1 release and arachidonic metabolism in monocytes in the absence of complement. Kidney Int 1988; 34: 67–73.

Shaldon S. , Deschodt G. , Branger B. Haemodialysis hypotension: the interleukin hypothesis restated. Proc EDTA-ERA 1985; 22: 220–45.

Flöge J. , Granolleras C. , Bingel M. β₂-microglobulin kinetics during haemodialysis and haemofiltration. Nephrol Dial Transplant 1987; 1: 223–8.

Lonnemann G. , Bingel M. , Floege J. , Koch K.M. , Shaldon S. , Dinarello C.A. Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int 1988; 33: S29–S35.

Luger A. , Kovarik J. , Stummvoll H. , Urbanska A. , Luger T.A. Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 1987; 32: 84–8.

Dodd N.J. , Gordge M.P. , Tarrant J. , Parsons V. , Weston M.J. A demonstration of neutrophil accumulation in the pulmonary vasculature during haemodialysis. Proc Eur Dial Transplant Assoc 1983; 20: 186–90.

De Backer W.A. , Verpooten G.A. , Borgonjon D.J. , Vermeire P.A. , Lins R.R. , De Broe M.E. Hypoxemia during hemodialysis: effects of different membranes and dialysate compositions. Kidney Int 1983; 23: 738–43.

Cheung A.K. , Baranowski R.L. , Wayman A.L. The role of thromboxane in cuprophan-induced pulmonary hypertension. Kidney Int 1987; 31: 1072–9.

Van den Bogaerde J.F. , Vanholder R.C. , Everaert J.A. Cardiac output-changes during hemodialysis with ultrafiltration. Clin Nephrol 1088; 29: 88–92.

Hakim R.M. , Breillatt J. , Lazarus J.M. , Port F.K. Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984; 311: 878–82.

Geijo F. , Odani S. , Yamada T. Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986; 30: 385–90.

Vanholder R. , Ringoir S. Beta 2-microglobulin kinetics during hemodialysis: lack of influence of membrane biocompatibility (to be published).

Jorstad S. Biocompatibility of different hemodialysis and plasmapheresis membranes. Blood Purification 1987; 5: 123–37.

Yewdall V.M.A. , Boscoe M.J. , Bennet-Jones D.N. , Cameron J.S. Clinical applications of crossed immunoelectrophoresis to the study of complement activation. J Clin Lab Immunol 1987; 24: 51–6.

Kasemo B. , Lausmaa J. Surface science aspects on inorganic biomaterials. CRC Crit Rev Biocomp 1986; 2: 335–80.

Kunin C.M. , Dobbins J.J. , Melo J.C. Infectious complications in four longterm recipients of the Jarvik-7 artificial heart. JAMA 1988; 259: 860–4.

Dobbins J.J. , Johnson G.S. , Kunin C.M. , Devries W.C. Postmortem microbiological findings of two total artificial heart recipients. JAMA 1988; 259: 865–9.

Gristina A.G. , Dobbins J.J. , Giammara B. , Lewis J.C. , Devries W.C. Biomaterial-centered sepsis and the total artificial heart. JAMA 1988; 259: 870–4.

Chu C.C. , Tsai W.C. , Yao J.Y. , Chiu S.S. Newly made antibacterial braided nylon sutures. I. In vitro qualitative and in vivo preliminary biocompatibility study. J Biomed Mat Research 1987; 21: 1281–300.

Marrie T.J. , Noble M.A. , Costerton W. Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. J Clin Microbiol 1983; 18: 1388–98.

Cowan M.M. , Taylor K.G. , Doyle R.J. Kinetic analysis of streptococcus sanguis adhesion to artificial pellicle. J Dent Res 1986; 65: 1278–83.

Cowan M.M. , Taylor K.G. , Doyle R.J. Energetics of the initial phase of adhesion of streptococcus sanguis to hy-droxylapatite. J Bacteriol 1987; 169: 2295–3000.

Inagaki H. , Hamazaki T. , Kuroda H. , Yano S. Foreign particles contaminating hemodialyzers and methods of removing them by rinsing. Nephron 1987; 40: 343–6.

Leong A.S.Y. , Disney A.P.S. , Gove D.W. Spallation and migration of silicone from blood-pump tubings in patients on hemodialysis. N Engl J Med 1982; 306: 135–40.

Morales J.M. , Colina F. , Arteaga J. Clinical implications of the presence of refractile particles in the liver of haemodialysis patients. Proc Eur Dial Transplant Assoc 1982; 19: 265–9.

Bommer J. , Waldherr R. , Ritz E. Silicone storage disease in longterm hemodialysis patients. Contrib Nephrol 1983; 36: 115–26.

Bommer J. , Ritz E. , Andrassy K. Necrotizing dermatitis resulting from hemodialysis with Polyvinylchloride tubings. Ann Intern Med 1979; 91: 869–70.

Ward R.A. , Feldhoff P.W. , Klein E. Role of dialyzer contaminants in the allergic epiphenomena of hemodialysis. Artif Organs 1984; 8: 338–45.

Aubuchon J.P. , Estep T.N. , Davey R.J. The effect of the plasticizer di-2-ethylhexyl phthalate on the survival of stored RBCs. Blood 1988; 71: 448–52.

Kevy S. , Jacobson M. Hepatic effects of the leaching of phthalate ester plasticizer and silicon. Contrib Nephrol 1983; 36: 82–9.

Nair N. , Kurup C.K.R. Effect of administration of diethyl-hexyl phthalate on the function and turnover of rat hepatic mitochondria. Biochim Biophys Acta 1987; 925: 332–40.

Crocker J.F.S. , Safe S.H. , Acott P. Effects of chronic phthalate exposure on the kidney. J Toxicol Environm Health 1988; 23: 433–44.

Fassbinder W. , Koch K.M. A specific immunohaemolytic anaemia induced by formaldehyde sterilisation of dialyzers. Contrib Nephrol 1983; 36: 51–67.

Vanholder R. , Noens L. , De Smet R. , Ringoir S. Development of anti-N-like antibodies during formaldehyde reuse in spite of adequate predialysis rinsing. Am J Kidney Dis 1988; 11: 477–80.

Michel R. Trace metal analysis in biocompatibility testing. CRC Crit Rev Biocomp 1987; 3: 235–317.

Vanholder R. , Ringoir S. Influence of reuse and of reuse sterilants on the first-use syndrome. Artif Organs 1987; 11: 137–9.

Marshall C. , Shimizu A. , Smith E.K.M. , Dolovich J. Ethylene oxide allergy in a dialysis center: prevalence in hemodialysis and peritoneal dialysis populations. Clin Nephrol 1984; 21: 346–9.

Dolovich J. , Marshall C.P. , Schmith E.K.M. Allergy to ethylene oxide in chronic haemodialysis patients. Artif Organs 1984; 8: 334–7.

Ing T.S. , Daugirdas J.T. Extractable ethylene oxide from cuprammonium cellulose plate dialyzers. Trans Am Soc Artif Intern Organs 1986; 32: 108–10.

Nicholls A.J. , Platts M.M. Anaphylactoid reactions during haemodialysis are due to ethylene oxide hypersensitivity. Proc Eur Dial Transplant Assoc 1984; 21: 173–7.

Bommer J. , Barth H.P. , Wilhelms O.H. , Schindele H. , Ritz E. Anaphylactoid reactions in dialysis patients: role of ethylene-oxide. Lancet 1985; 2: 1382–4.

Rostoker G. , Robin J. , Binet O. , Paupe J. Dermatoses d'intolérance aux métaux des matériaux d'ostéosynthèse et des prothèses. Ann Dermatol Vénéréol 1986; 113: 1097–108.

Leonard E.F. , Van Vooren C. , Hauglustaine D. , Haumont S. Shear-induced formation of aggregates during hemodialysis. Contrib Nephrol 1983; 36: 34–5.

Leonard E.F. Dialysis membranes. Proc Eur Dial Transplant Assoc 1984; 21: 99–110.

Jen C.J. , McIntire L.V. Characteristics of shear-induced aggregation in whole blood. J Lab Clin Med 1984; 103: 115–24.